Quest Diagnostic Receives the US FDA's First EUA for Sample Pooling in COVID-19
Shots:
- The US FDA has authorized Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to 4 individual swab specimens collected under observation. The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples
- Quest Diagnostic expects to deploy the technique at its laboratories in Chantilly- VA and Marlborough- Mass.- by the end of next week with additional laboratories to follow
- The company has received the FDA’s EUA for use of self-collection molecular diagnostic kit on the Hologic and Roche’s platforms- expanding use with healthcare provider supervision via telemedicine
Ref: PRNewswire | Image: Glassdoor
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com